Talking of CEOs, there is a new one at antibody discoverer Visterra.
Dr. Brian Pereira will replace Steven Brugger in the role of CEO and President, as well as taking a place on the Board. He previously served as President and CEO of AMAG Pharmaceuticals between 2006 and 2011, and before that he was President and CEO of a Tufts Medical Center Physician Organization.
“Brian brings his proven industry leadership with an impressive track record for managing high-performance teams and building significant company value, and these skills will augment the expertise of the existing Visterra team to advance the company’s strategy and product development programs,” said Alan Crane, Visterra’s Chairman.
On the eve of the historical vote on Scottish independence from the UK tomorrow, we take a...
Who's in, who's out: all the latest changes in senior pharmaceutical appointments.
Plus senior hires at Merck Serono, Astellas, the European Medicines Agency, and more.
Our People on the Move column tracks pharma's movers and shakers.